INS and hypertensive disorder: Although some variables (i.e., age, hypertension, statin, angiotensin converting enzyme inhibitor/angiotensin receptor blocker, calcium channel blocker, sulfonylurea, insulin, acarbose, rosiglitazone, aspirin and dipyridamole) differed significantly, none had a value of standardized difference > 10% (Table 1).